Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cerebral Palsy
National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births
September 11th, 2008
Results of a 10-year study published in the August 28 issue of the New England Journal of Medicine found that magnesium sulfate administered to women delivering before 32 weeks of gestation reduced the risk of cerebral palsy by 50 percent. The Beneficial Effects of Antenatal Magnesium Sulfate (BEAM) trial was conducted in 18 centers in the U.S., including Northwestern Memorial, and is the first prenatal intervention ever found to reduce the instance of cerebral palsy related to premature birth. Magnesium sulfate is traditionally used in obstetrics to stop premature labor and prevent seizures in women with hypertension. The BEAM trial studied the link between magnesium...
Source: Women's Health Weekly (2008-09-11)
|
